Clinical trials
Percutaneous Coronary Intervention clinical trials
Below are recruiting percutaneous coronary intervention clinical trials, each written for real people, not researchers. We’re tracking 164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07366684Recruiting
Heart attack study for adults 75 and older
This study looks at how frailty and other health factors affect recovery in people 75 and older who have had a heart attack or unstable chest pain. It may help doctors better understand who is at higher risk and how to improve care for older adults.
NišAges 75 years+ - NCT05490238Recruiting
Wrist vs arm access for complex heart procedures
This study compares using the wrist (radial artery) versus a different access site (conventional radial access approach) during complex, larger “bore” heart procedures to open blocked coronary arteries. It aims to see which approach is safer and works better for challenging cases like chronic blockages or heavily calcified arteries.
ArlonAges 18 years+ - NCT06274411Recruiting
Backup ECMO for high-risk heart stenting
This trial studies a safe, backup ECMO machine for people with very weak hearts or complex blockages who need high-risk stenting. It helps keep your blood pumping if your heart struggles during the procedure.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06669520Recruiting
Renalase and blood vessel blockages after heart attack
This study is looking at a protein in the blood (renalase) and how it relates to blockages in tiny blood vessels after a heart attack. Researchers want to see if this protein can help predict recovery, which could lead to better treatments.
Changsha, HunanAges 18 years+ - NCT06930092Recruiting
Stents to improve heart function in heart failure
This study tests whether opening blocked heart arteries with stents can improve heart function in people with heart failure caused by coronary artery disease. It may be an option if your heart is weak and you have multiple blockages but no recent heart attack or dangerous rhythm.
Seoul, Chongno-guAges 19 years+ - NCT06460571Recruiting
Exercise after heart stent: with or without Delorme technique
This trial compares two types of cardiac rehab exercises for people age 70+ who recently got their first heart stent. It aims to see if adding progressive resisted exercises (the Delorme technique) helps improve breathing and recovery.
Sialkot, Punjab ProvinceAges 70–80 - NCT07297641Recruiting
Imaging-guided vs X-ray-guided PCI for blocked stents
This trial compares two ways to guide a procedure to reopen a stent that has narrowed again: using a special camera inside the artery (IVUS) versus standard X-ray (angiography). It aims to see which approach works better for people who have a drug-eluting stent that is narrowing for the first time.
Nanjing, JiangsuAges 18–80 - NCT07001332Recruiting
High-risk heart stent procedure study
This study tests a new device to help people with high-risk blockages in their heart arteries during a stent procedure. It compares the new device to standard treatment to see if it is safe and effective.
Phoenix, ArizonaAges 18–88 - NCT05828719Recruiting
Compare heart stent treatment vs medicines for weak heart function
This study looks at whether opening blocked heart arteries with a stent (a PCI procedure) works better than staying on heart medicines for people with weakened pumping function and certain types of heart failure. It may help patients by testing which approach best improves outcomes over time.
SeoulAges 19 years+ - NCT05334784Enrolling by invitation
Heart pump study for planned high-risk heart stent procedures
This study looks at using a temporary heart pump called Impella ECP during planned high-risk heart stent procedures (PCI). It may help doctors support the heart more safely while placing the stents.
Phoenix, ArizonaAges 18–90 - NCT04049591Recruiting
Higher vs lower heparin dose during planned heart stent procedure
This trial compares a higher versus lower dose of heparin (a blood thinner) during a planned PCI, which is a heart procedure to open blocked arteries using a stent. It may help hospitals and patients know which dosing approach is safest and works well during the procedure.
Hamilton, OntarioAges 18 years+ - NCT04899479RecruitingPhase 4
SGLT-2 inhibitor after heart attack to improve heart recovery
This trial studies whether starting an SGLT-2 inhibitor around the time of a heart attack can reduce heart damage size and improve how the heart heals. It focuses on people with a high risk of developing heart failure and who are getting a procedure to open blocked heart arteries.
SeoulAges 18 years+ - NCT04912518Recruiting
Dexmedetomidine for heart protection after a specific heart attack
This study tests whether dexmedetomidine can protect the heart in people who are having a specific type of heart attack (anterior STEMI) when treated within 6 hours of symptom start. You may be considered if your diagnosis and vital signs fit the study safety rules, and if you can take part in follow-up.
Hefei, AnhuiAges 18–75 - NCT05353140Recruiting
Left atrial appendage device vs blood thinners after stent
This trial compares a heart device that can help prevent blood clots in the heart (called LAAO) versus long-term blood thinners for people who have atrial fibrillation and recently had a stent placed. It aims to see which approach better prevents stroke and related blood-clot problems while keeping side effects manageable.
Xi'an, ShannxiAges 18 years+ - NCT05709626RecruitingPhase 4
Testing prasugrel alone after stent placement for heart attack
This study checks whether taking prasugrel by itself, after you get a drug-eluting stent for a heart attack (STEMI), can work as well as the standard approach. It may help prevent blood clots in the stent, but it requires specific blood-thinner plans for 12 months.
Sayama, OsakaAges 18 years+ - NCT05728580Recruiting
Study of PCI results at Beijing Friendship Hospital
This trial is for adults who already had a PCI procedure for coronary heart disease and had a successful result. The study looks at how PCI was done in practice and may help improve future treatment and follow-up.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05955365RecruitingPhase 4
Single anticoagulant blood thinner after stent in atrial fibrillation
This trial tests whether taking a single “P2Y12 inhibitor” blood thinner (instead of multiple medicines) is safe and effective after you get a coronary stent. It’s for people with atrial fibrillation who need long-term blood thinning and have recently had a successful stent procedure.
HasseltAges 18 years+ - NCT05986968Recruiting
Testing ticagrelor alone after a heart attack and stent
This trial tests whether a single blood thinner (ticagrelor) is safe and helps reduce bleeding in the heart muscle in people who have had a specific type of heart attack (STEMI) and a stent. It may be an option if you want to avoid taking aspirin with ticagrelor.
AlkmaarAges 18 years+ - NCT07687576RecruitingPhase 2/Phase 3
Comparing clot removal methods for heart attack patients
This trial tests if a special device that sucks out blood clots during a heart attack is better than standard care for reducing clot size before placing a stent. It may help patients who have a large clot and a blocked artery.
Oxford, OxfordshireAges 18 years+ - NCT06463808Recruiting
Heart recovery after heart attack with added protein therapy
This trial tests if adding a protein called rhBNP (which helps the heart relax) to standard care after a heart attack and stent improves heart recovery and pumping strength over time.
Nanjing, JiangsuAges 18–75 - NCT06521801Recruiting
The Heart-Kidney Health Registry Study
This is an observational registry that collects information from people with kidney disease who are seen by the kidney team at Royal London Hospital. It helps researchers study heart and kidney health over time without needing extra tests or visits.
LondonAges 16 years+ - NCT06567249Recruiting
Cooling the heart during a heart attack procedure
This study tests whether cooling the heart with a cold liquid during a procedure (angioplasty) can help reduce damage after a heart attack. It may be an option for people who arrive at the hospital quickly after a heart attack.
TomskAges 18–90 - NCT06654453Recruiting
Clot removal during heart catheterization after clot-busting medicine
This study tests whether removing a clot with a special suction device during a heart catheterization helps people who already received a clot-busting medicine for a severe heart attack. It may improve blood flow and reduce damage to the heart muscle.
Changsha, HunanAges 18 years+ - NCT06788275Recruiting
Can exercise improve blood vessel health after a heart attack?
This study looks at whether aerobic exercise can improve blood vessel health in people who have had a heart attack or chest pain (angina). If you qualify, you'll join a monitored exercise program.
Alicante, AlicanteAges 45–75
Hear when a new Percutaneous Coronary Intervention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for percutaneous coronary intervention?
- Yes. Clin2 currently lists 164 recruiting percutaneous coronary intervention studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a percutaneous coronary intervention trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a percutaneous coronary intervention trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.